First Human Trial of Age-Reversing Treatment Conducted

Kathmandu. A treatment claimed to have the potential to reverse the aging process has been tested on a human body. This is the first time an injection to stop aging in humans has been administered.

The US-based biotech startup company 'Life BioSciences' has stated that a new 'cellular reprogramming' injection was given to a patient. In the trial, the injection was administered into the cornea of a patient suffering from glaucoma.

The main objective of this trial is to return aged and weakened cells to a youthful state. For the next six months, scientists will closely study the efficacy and potential risks of this treatment.

So far, the company has not released detailed information about the patient. It is hoped that this could open the door to age-related treatments for the entire body in the future.

This technology is based on 'epigenetic reprogramming', which attempts to revert cells to a youthful state by altering the way genes are expressed within them.

Significant investment has increased in this concept in recent years. World-renowned businessmen Jeff Bezos and Sam Altman, as well as major pharmaceutical companies Eli Lilly and Merck, have also increased investment in longevity research.

Life BioSciences CEO Jerry McLaughlin has called this a potentially historic turning point for medical science.

According to him, if the trial is successful, it could usher in a new era in the treatment of age-related diseases in humans. However, according to experts, this technology is still in its early stages, and it will take a long time to prove its real effects and safety.